Table 3.
Haematology and blood biochemistry findings in study III
| Placebo | Ciclesonide 2700 μg | Ciclesonide 3712.5 μg am | Ciclesonide 3712.5 μg pm | |
|---|---|---|---|---|
| PCV [%] | ||||
| Day 0 | 34 ± 5 | 35 ± 4 | 35 ± 2 | 35 ± 4 |
| Day 14 | 34 ± 5 | 34 ± 3 | 34 ± 4 | 34 ± 5 |
| Day 21 | 32 ± 4 | 33 ± 3 | 36 ± 4 | 33 ± 5 |
| Total proteins [g/L] | ||||
| Day 0 | 68.2 ± 2.4 | 69.7 ± 3.1 | 71.1 ± 3.6 | 69.9 ± 3.7 |
| Day 14 | 71.1 ± 2.3 | 69.7 ± 2.8 | 69.4 ± 3.9 | 68.0 ± 4.2 |
| Day 21 | 70.0 ± 2.0 | 67.1 ± 3.4 | 69.0 ± 4.2 | 68.0 ± 3.6 |
| WBC [×109/L] | ||||
| Day 0 | 6.7 ± 0.8 | 6.8 ± 0.6 | 6.9 ± 1.0 | 6.6 ± 1.3 |
| Day 14 | 7.0 ± 1.5 | 7.4 ± 1.6 | 7.3 ± 1.2 | 7.2 ± 1.1 |
| Day 21 | 6.7 ± 1.3 | 6.3 ± 1.0 | 6.8 ± 1.3 | 6.3 ± 0.8 |
| Segmented neutrophils [×109/L] | ||||
| Day 0 | 4.1 ± 1.0 | 4.0 ± 0.8 | 4.4 ± 1.0 | 3.7 ± 1.2 |
| Day 14 | 4.3 ± 1.3 | 4.6 ± 1.4 | 4.4 ± 1.0 | 4.4 ± 1.2 |
| Day 21 | 3.9 ± 1.1 | 3.5 ± 0.8 | 3.7 ± 1.1 | 3.4 ± 0.7 |
| Lymphocytes [×109/L] | ||||
| Day 0 | 2.3 ± 0.5 | 2.5 ± 0.6 | 2.2 ± 0.3 | 2.5 ± 0.4 |
| Day 14 | 2.3 ± 0.2 | 2.5 ± 0.6 | 2.5 ± 0.5 | 2.4 ± 0.3 |
| Day 21 | 2.5 ± 0.3 | 2.5 ± 0.5 | 2.7 ± 0.5 | 2.5 ± 0.3 |
Data presented as mean ± s.d. PCV, packed cell volume; WBC, white blood cells.